OpenAI is engaged in preliminary discussions with private investors regarding a new capital injection that could elevate the artificial intelligence enterprise’s valuation to approximately $1.2 trillion.
Initiated directly by institutional investors seeking premier artificial intelligence exposure, the prospective round follows significant revenue acceleration triggered by recent model launches. If finalized, the transaction would fortify the company’s balance sheet while granting executive leadership additional flexibility to recalibrate its public listing timeline.
The proposed $1.2 trillion valuation represents a substantial increase from March, when the company secured $122 billion in committed capital at an $852 billion post-money evaluation. Commercial momentum has accelerated following the deployment of the GPT-5.6 and Astra architectures, which propelled annualized revenue past $40 billion last month—a 20 percent sequential expansion.
This top-line growth serves as a counterweight to significant operational expenses, following $34 billion in cash burn last year driven by frontier model development. In addition to supporting ongoing operations, new capital could fund further corporate acquisitions, extending an expansion strategy that previously included purchases of developer toolmaker Astral and Jony Ive’s hardware startup io.
While OpenAI confidentially submitted an initial public offering prospectus in June, Chief Executive Officer Sam Altman clarified that a market launch will not occur in 2026. Altman cited broader industry safety concerns and market readiness as primary factors delaying the listing until 2027 or later. Extending the private growth phase enables existing equity holders, such as SoftBank and Thrive Capital, to expand their ownership stakes prior to a public flotation, though it defers liquidity events for early investors.
Furthermore, securing supplementary private capital provides operational flexibility to push back the initial public offering by one or two quarters while navigating legal boundaries regarding pre-IPO disclosures to private market participants.
